Axon Enterprise (NASDAQ:AXON) CFO Sells $1,525,000.00 in Stock

Axon Enterprise, Inc (NASDAQ:AXON) CFO Brittany Bagley sold 2,500 shares of the company’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $610.00, for a total transaction of $1,525,000.00. Following the completion of the transaction, the chief financial officer owned 91,092 shares in the company, valued at approximately $55,566,120. The trade was a 2.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Brittany Bagley also recently made the following trade(s):

• On Monday, September 29th, Brittany Bagley sold 5,000 shares of Axon Enterprise stock. The shares were sold at an average price of $713.88, for a total value of $3,569,400.00.
• On Monday, September 15th, Brittany Bagley sold 870 shares of Axon Enterprise stock. The stock was sold at an average price of $773.25, for a total value of $672,727.50.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $554.37 on Friday. Axon Enterprise, Inc has a 12 month low of $469.24 and a 12 month high of $885.91. The stock’s fifty day moving average price is $702.88 and its 200-day moving average price is $735.01. The firm has a market cap of $43.75 billion, a P/E ratio of 136.88, a P/E/G ratio of 29.49 and a beta of 1.45. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $710.64 million for the quarter, compared to analysts’ expectations of $704.83 million. During the same period last year, the business posted $1.45 EPS. The company’s revenue for the quarter was up 30.6% on a year-over-year basis. On average, equities research analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

Several institutional investors and hedge funds have recently made changes to their positions in AXON. TCTC Holdings LLC lifted its position in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after acquiring an additional 24 shares during the period. Stone House Investment Management LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth about $29,000. New Millennium Group LLC purchased a new stake in Axon Enterprise in the third quarter valued at approximately $29,000. Banque Transatlantique SA purchased a new stake in Axon Enterprise in the first quarter valued at approximately $31,000. Finally, Flaharty Asset Management LLC acquired a new position in Axon Enterprise in the 1st quarter worth approximately $33,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on AXON. Needham & Company LLC reiterated a “buy” rating and issued a $870.00 price target on shares of Axon Enterprise in a report on Wednesday, September 24th. JMP Securities reiterated a “market outperform” rating and issued a $825.00 target price on shares of Axon Enterprise in a report on Monday, September 29th. Raymond James Financial restated an “outperform” rating and issued a $855.00 price target (up from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Piper Sandler decreased their target price on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Finally, Bank of America raised their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $810.71.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.